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Background
Production of human monoclonal antibodies with broad
neutralizing activity is an essential part of HIV-1 pro-
phylactic vaccine. Majority of the viruses infecting
Indian patients belong to clade C.
Methods
A phage library of 7000 clones was constructed from a
drug naive HIV-1 clade C infected Indian patient
whose plasma exhibited high potential neutralizing
potential against a panel of viruses and also displayed
cross-reactive anti-V3 antibodies. PBMCs were iso-
lated and EBV transformed. Cells (wells) producing
anti-V3 antibodies were preselected with V3-CTB
fusion protein and expanded. Total RNA was isolated
a n dc D N Aw a sc o n s t r u c t e df o l l o w e db yV Ha n dV L
amplification. scFvs were constructed, cloned into
phagemid vector and expressed in Escherichia coli.
We assessed the expression of the scFvs by SDS-
PAGE and Western blotting. Specificity was examined
by ELISA.
Results
A total of 30 clones were randomly selected after bio-
panning and checked for their binding to V3 peptides of
clade C and B. Ten clones showed binding in phage
ELISA, 8 were cross-reactive to both the V3 peptides
while the other 2 were specific to V3C. The clones did
not show cross-reactivity against other unrelated pep-
tides. The recombinant anti-V3 scFvs (32kD) were
expressed and confirmed by SDS-PAGE and Western
blotting. DNA fingerprinting analysis showed that 9 out
of the 10 clones were distinct.
Conclusion
This is the first report on the generation of human anti-
V3 scFvs against HIV-1 clade C. Further assessment of
the neutralization efficiency of these scFvs would reveal
their potential for passive immunotherapy.
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